CELF1, a Multifunctional Regulator of Posttranscriptional Networks by Beisang, Daniel et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8 
 
 
 
 
© 2012 Vlasova-St. Louis et al., licensee InTech. This is an open access chapter distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
CELF1, a Multifunctional Regulator  
of Posttranscriptional Networks 
Daniel Beisang, Paul R. Bohjanen and Irina A. Vlasova-St. Louis  
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/48780 
1. Introduction 
In order to assure the precise utilization of genetic information, gene expression is regulated 
at the level of transcription as well as multiple post-transcriptional levels including splicing, 
transport, localization, mRNA stability, and translation [1],[2],[3],[4],[5],[6],[7]. During 
evolution, cells developed precise mechanisms to ensure that each transcript is 
appropriately stored, modified, translated or degraded, depending on the need for the 
mRNA or encoded protein by the cell. Steady-state protein levels within a cell correlate 
poorly with steady-state levels of mRNA, leading scientists to hypothesize that the gene 
expression is regulated at post-transcriptional levels [8]. Work over the past quarter century 
has resulted in the identification of unifying concepts in post-transcriptional regulation. One 
unifying concept states is that post-transcriptional regulation is mediated by two major 
molecular components: cis-acting regulatory sequence elements and trans-acting factors. Cis-
acting regulatory sequence elements are sub-sequences contained in the 5’ untranslated 
region (UTR), coding region, and 3’UTR of mRNA that are selectively recognized by a 
complementary set of one or more trans-acting factors to regulate post-transcriptional gene 
expression.  Trans-acting factors include RNA-binding proteins (RBPs) and microRNAs 
(miRNAs) which are able to influence the fate of  mRNA by controlling processes such as 
translation and mRNA degradation  (reviewed in references [9],[10],[11],[12]). The 
combinatorial interplay between various miRNAs and RBPs binding to a given mRNA 
allows for the transcript specific regulation critical to many cellular decisions during 
development [13],[14],[15],[16] and in response to environmental stimuli (reviewed in 
references [17],[18],[19],[20],[21],[22]).  
Various experimental approaches have been developed to understand the interaction 
between RBPs and the network of transcripts that they regulate.  One of the most widely 
used techniques involves immunopurification of specific RNA-binding proteins from 
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cellular extracts followed by high-throughput analysis of the co-purified RNA species [23].  
The coupling of this technique to powerful bioinformatic analysis methods has lead 
researchers to understand the binding specificity of a wide-variety of RBPs.  The advent of 
new technology such as next generation sequencing and chemical cross-linking procedures 
have improved these methodologies and allowed for the fine-scale mapping of RBP binding 
sites, as well as the refinement of RBP binding motifs.  Microarray-based studies that 
evaluated mRNA decay rates on a global basis have also provided valuable information 
about the role of post-transcriptional regulation of a wide variety of transcripts that have 
important physiological functions  [24],[25],[26],[27],[28],[29].   
This chapter focuses on the role of CELF1 (CUGBP and embryonically lethal abnormal 
vision-type RNA binding protein 3-like factor 1) in the regulation of posttranscriptional 
gene expression.  CELF1 functions to regulate posttranscriptional gene expression by 
binding to RNA sequences known as GU-rich elements (GREs).  Genome-wide 
measurements of mRNA decay and bioinformatic sequence motif discovery methods were 
used to identify the GRE as a highly conserved sequence that was enriched in the 3’UTR of 
mRNA transcripts with short half lives in primary human T lymphocytes [30].  This 
sequence resembled previously characterized binding sites for CELF1 [31],[32], and CELF1 
was found to bind with high affinity to GRE sequences and mediate mRNA degradation 
[30].  This chapter reviews how CELF1 and its target transcripts function as an 
evolutionarily conserved posttranscriptional regulatory network which plays important 
roles in health and disease. 
2. Evolutionary conservation of CELF proteins  
The CELF protein family is an evolutionarily conserved family of RNA-binding proteins 
that play essential roles in post-transcriptional gene regulation [28],[33]. These proteins 
contain three highly conserved RNA-Recognition Motifs (RRM) with the 2 N-terminal RRMs 
and the C-terminal RRM being separated by a highly divergent linker domain [34].  The 
RRMs confer RNA binding activity, and it is postulated that the divergent linker domain is 
an important site for functional regulation.  Six members of the CELF family have been 
identified in humans and mice:  CELF1 (CUGBP1) and CELF2 (CUGBP2) proteins are 
expressed ubiquitously and play vital role in embryogenesis [35],[36],[37],[38],[39], whereas 
CELF proteins 3-6 are restricted to adult tissues and found almost exclusively in the nervous 
system [40],[41].  CELF proteins often serve multiple functions in both the cytoplasm and 
the nucleus [42],[43]. Human CELF1 and its orthologs  in Gallus gallus, Zebrafish, Xenopus, 
Drosophila and C. elegans have been known for many years to regulate gene expression at 
posttranscriptional levels and to control important developmental processes 
[31],[44],[45],[46],[47],[48],[49].   
CELF1 function is conserved across evolution at the level of biochemical mechanism as well 
as its function in regulating development.  Transcript deadenylation is often the first step in 
the mRNA degradation process, and CELF1 has been shown to promote transcript 
deadenylation in diverse species [28],[50]. In Xenopus embryos the CELF1 homologue 
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Embryo Deadenylation Element Binding Protein (EDEN-BP), which is 88% identical to 
CELF1, regulates transcript deadenylation, and human CELF1 was able to functionally 
replace the deadenylation function of EDEN-BP in Xenopus extracts [51]. In HeLa cell 
extracts CELF1 also promotes transcript deadenylation and was shown to recruit PolyA 
Ribonuclease (PARN) [52].  In addition to the evolutionary conservation of the biochemical 
function of CELF1, the developmental programs regulated by CELF1 may also be 
conserved.  For example, CELF1 appears to be an important factor in muscle development in 
diverse species.  Studies investigating the function of CELF1 in Drosophila, Xenopus and mice 
have shown that CELF1 is critical for regulating the muscle developmental program [45], 
[53], [54]. More recent work suggests that CELF1 is a crucial factor in the regulation of 
mRNA degradation in mouse myoblasts [55].  Thus, in addition to the conservation of its 
biochemical function as a regulator of deadenylation, the role of CELF1 in muscle 
development may also be conserved.   
As described below, CELF proteins from diverse species bind to RNA preferentially at GU-
rich sequences and thereby regulate post-transcriptional processes such as mRNA splicing, 
translation, deadenylation and mRNA degradation. The structure and biochemical 
properties of CELF family members suggest functional redundancy [56], yet each CELF 
protein targets specific sub-populations of RNA transcripts and appears to have distinct 
functions  [57]. We are starting to understand the mechanisms by which an individual CELF 
protein can serve multiple biochemical functions to coordinately regulate gene expression at 
posttranscriptional levels [30]. 
3. Biochemistry of binding by CELF proteins to target mRNA   
CELF 1 and 2 proteins were first isolated and characterized as novel heterogeneous nuclear 
ribonucleoproteins (hnRNPs). Timchenko et.al. demonstrated that these proteins bound to 
RNA containing the sequence (CUG)8  within the 3'UTR of  myotonin protein kinase mRNA 
in vitro [58],[59]. Subsequent searches for the RNA-binding specificities of CELF1 and CELF2 
used systemic evolution of ligands exponential enrichment (SELEX), revealing that CELF1 
and CELF2 both bound preferentially to GU-rich RNA sequences [60]. Binding by CELF1 to 
GU-rich sequences in vitro and in vivo was abrogated by mutation of G nucleotides to C 
[30],[61]. Takanashi et. al. used a yeast three hybrid system for evaluating RNA-protein 
interactions, and found CELF1 bound preferentially to UG repeats rather than to CUG 
repeats [32]. CELF1 bound with high specificity to (UG)15 based on a surface plasmon 
resonance (SPR) quantitative binding assay [62].  Orthologues of CELF1 in other species also 
appear to have preferences for binding to GU-rich sequences.  In Xenopus, the CELF1 
orthologue EDEN-BP (embryo deadenylation element binding protein) binds to the GU-rich 
EDEN element, which contains the sequence (UGUA)12, and functions as a deadenylation 
signal in Xenopus embryos after fertilization [31],[51]. In Drosophila, the CELF1 orthologue 
Bru-3 was found to bind specifically to (UG)15 repeats and also was able to bind to the 
Xenopus  EDEN element [46]. The Zebrafish protein Brul, a homologue of EDEN-BP with 81% 
identity, was also shown to preferentially bind to GU-rich RNAs [63]. EDEN-BP and Bru-3 
can bind to GRE-RNA as dimers [64],[65] and may require GU-rich sequences of sufficient 
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length to allow dimer formation [66].  In addition to the primary GU-rich sequence, adjacent 
sequence elements may also be important for assembly of CELF proteins on RNA by 
allowing optimal secondary structure to facilitate the formation of RNA-protein complexes 
[67],[68].  
Structural studies have provided valuable insight into the mechanisms underlying the RNA- 
binding activity of CELF1.  CELF proteins all contain two N-terminal and one C-terminal 
RNA recognition motifs (RRMs), separated by a 160-230 residue divergent domain [69],[70]. 
The highly conserved RRMs bind to RNA in a sequence-specific manner [69],[71]. Nuclear 
Magnetic Resonance spectroscopic (NMR)-based solution studies demonstrated that both 
RRM1 and RRM2 each contribute to binding to a 12-nt target RNA containing two UUGUU 
motifs. The tandem RRM1/2 domains together show increased affinity compared to the 
binding by each domain separately to an RNA sequence with two sequential UUGU(U) 
motifs, thus indicating binding cooperativity between the two RRMs [34],[72]. 
Crystallographic studies showed that both RRM2 and RRM1 bind to GRE-RNA, and RRM1 
is important for crystal-packing interactions [73].  
In addition to RRM1 and RRM2, RRM3 also has RNA-binding activity.  According to NMR 
analysis, RRM3 specifically recognizes the UGU trinucleotide segment of bound (UG)3 RNA 
through extensive stacking and hydrogen-bonding interactions within the pocket formed by 
the beta-sheet and the conserved N-terminal extension [71]. Experiments investigating 
CELF1 function through a yeast three hybrid system suggested that deletion/mutation of 
RRM1 or RRM2 does not abrogate binding to GU-rich RNA, suggesting that RRM3 may 
recognize GU-repeats more avidly than RRM1 or RRM2 [62].  Additionally, it has been 
reported that RRM3 is able to recognize a poorly defined G/C-rich sequence from the 5’UTR 
of Cyclin D1 when combined with the divergent domain [65]. The divergent domain also 
appears to be important for RNA-binding since the presence of divergent domain within 
recombinant CELF1/CELF4 chimeric proteins increased RNA-binding affinity, perhaps by 
conveying important conformational changes necessary for RNA-binding [32],[62],[70].  The 
divergent domain may also facilitate CELF:CELF homotypic interactions [64] which may 
influence its activity.  For example, CELF:CELF interactions appear to activate RNA 
deadenylation in Xenopus extracts [66].   
3.1. Regulation of CELF1 function through phosphorylation 
CELF1 is a known phosphoprotein with multiple predicted phosphorylation sites, and 
CELF1 phosphorylation appears to regulate its function as a mediator of alternative splicing, 
mRNA decay, and translational regulation [74],[75],[76],[77].  One of the pathologic events 
which occurs in the disease Myotonic Dystrophy type 1 (DM1) is an increase in the protein 
abundance of CELF1 and an associated increase in CELF1 mediated alternative splicing 
activity.  This increase in CELF1 protein abundance is a result of increased CELF1 protein 
stability secondary to hyperphosphorylation [75].  In DM1, the (CUG)n expansion of the 
DMPK 3’UTR leads to protein kinase C (PKC) activation through an unknown mechanism.  
PKC, in turn, hyperphosphorylates CELF1, resulting in increased protein stability and 
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abundance as well as increased splicing activity [78].  Additionally, in transgenic mouse 
models of DM1, mice treated with specific inhibitors of the PKC pathway showed 
amelioration of cardiac abnormalities associated with the disease phenotype [79]. 
Phosphorylation of CELF1 also influences its ability to regulate muscle development 
(reviewed in [80]).  CELF1 phosphorylation by Akt kinase at Ser 28 in normal muscle 
myoblasts influences its ability to affect the translation of its target transcripts during 
differentiation [65]. Phosphorylation of CELF1 also directly influences its RNA-binding 
activity.  For example, cyclin D3-Cdk4/6 phosphorylates CELF1 at Ser 302, altering the 
binding specificity of CELF1 to RNA and translation initiation proteins, such as eIF2α [81].  
During the process of T cell activation, phosphorylation of CELF1 alters binding by CELF1 
to target transcripts.  Shortly following T cell activation, CELF1 becomes phosphorylated, 
dramatically decreasing its affinity for mRNA and leading to stabilization of CELF1 target 
transcripts [77].  Overall, these studies show that phosphorylation regulates the many 
functions of CELF1 in posttranscriptional gene regulation. 
3.2. Identification of CELF1 target transcripts 
Insight into the biological significance of CELF1 function as a coordinate regulator of post-
transcriptional network was revealed through the experimental determination of CELF1 
target transcripts. A technique involving RNA-immunoprecipitation followed by 
microarray analysis of associate transcripts (RIP-Chip) has allowed for the unbiased, 
genome-wide experimental identification of RNA-binding protein target transcripts. This 
technique involves immunoprecipitating an RNA-binding protein of interest from cell 
lysates under conditions that preserve RNA:Protein interactions.  The co-purified RNA 
found associated with the immunoprecipitated RNA-binding protein is then isolated and 
interrogated using high throughput methods such as microarrays.  Using this 
methodology, CELF1 targets have been identified in HeLa cells, resting and activated 
human T cells, and mouse myoblasts [55],[77],[82].  CELF1 targets, identified in 
cytoplasmic extracts from HeLa cells using an anti-CELF1 antibody, were analyzed to 
identify the CELF1 target sequence, which is known as the GRE.  The sequence profile of 
CELF1 target transcripts was analyzed for enriched sequences using a Markov Chain 
Monte Carlo based gibbs sampler algorithm (BioProspector) as well as an 
overrepresentation algorithm, and the previously described GRE sequence, 
UGUUUGUUUGU, and a GU-repeat sequence, UGUGUGUGUGU, were found to be 
highly overrepresented in the 3’UTRs of the CELF1 target transcripts [83].  Both sequences 
were validated as CELF1-binding targets and were shown to function as mRNA decay 
elements by accelerating the decay of reporter transcripts.  While GU-repeat sequences had 
previously been identified as a CELF1 recognition motif through in vitro SELEX protocol 
[60]. These and other experiments identified putative binding targets of CELF1 in cells 
[32],[62]. Because (as described later in this chapter) the UGUUUGUUUGU sequence and 
the GU-repeat sequence both bound to CELF1 and functioned as decay elements, the GRE 
was redefined to contain both of these sequences [83],[84]. The RIP-Chip approach was also 
used to immunoprecipitate endogenous RNA binding complexes from mouse myoblasts, 
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using an anti-CELF1 antibody and similar G and U rich target sequences were identified 
[55]. In Xenopus extracts, target transcripts identified by RIP-Chip using an antibody 
against the CELF1 sequence homolog, EDEN-BP, were enriched in GU-rich sequences very 
similar to GREs [85]. These GU-rich containing target transcripts represented 
approximately 5% of the tested transcripts on the microarray [85].  In this work, the authors 
proposed a 15-nucleotide consensus motif (UGU/UG)3 to be the target motif of EDEN-BP 
[85],[86].  The RIP-Chip approach was also used to investigate the cytoplasmic target 
transcripts of CELF1 in resting and activated primary human T cells, and target transcripts 
were highly enriched for the presence of the GRE in their 3’UTRs, but the number of CELF1 
target transcripts decreased dramatically following T cell activation [77]. Overall, 
numerous CELF1 target transcripts have been identified in several different systems 
indicating the CELF1 functions to regulate an important posttranscriptional network of 
gene expression.  
Another approach to identify targets of RNA-binding proteins utilizes a cross-linking step 
prior to immunoprecipitation (CLIP) and subsequent high throughput methods to 
identify protein binding sequences. Using this method, 315 CELF1 RNA targets were 
identified in whole cell extracts from mouse hindbrain [87]. These RNA-binding targets 
for CELF1 were enriched in UG repeat sequences, with 64% of target sequences found in 
introns and 25% found in 3’ UTR sequences [87]. Similar analysis of CELF1 in the C2C12 
mouse myoblast cell line [88] extensively characterized RNA-binding sites of CELF1 and 
found that CELF1 bound predominantly in 3’UTRs and caused mRNA decay. The authors 
found significant enrichment of CELF1 binding sites in intronic regions flanking exons, 
supporting a role for CELF1 in alternative splicing [88]. Overall, these studies suggest that 
GU-rich sequences serve as genuine binding sites for CELF1 in a manner that has been 
conserved through evolution. In the next sections, we review the data supporting the 
model that CELF1 recognizes GU-rich sequences and thereby regulates pre-mRNA 
splicing, translation, and/or mRNA deadenylation/decay depending on the cellular and 
environmental context. 
4. CELF1 as a regulator of splicing  
Pre-mRNA alternative splicing is a common mechanism for generating transcript and 
protein diversity. An estimated 90% of human genes produce alternatively spliced 
transcripts [89],[90]. Alignment of the genomic regions adjacent to mammalian intron-exon 
splice sites, identified TG-rich motifs (TTCTG and TGTT) as conserved cis-elements found at 
splicing acceptor sites associated with alternative splicing [91],[92]. These C/UG-rich 
sequences serve as binding sites for CELF proteins which activate or repress the splicing of 
pre-mRNA targets, depending on the context [93]. Recent evidence has re-confirmed the 
position-dependence of CELF1-binding sites in regulating exon inclusion or skipping 
(Figure 1) [88]. Although alternative splicing regulation was initially considered the primary 
function of CELF1 proteins in the nucleus, CELF members have also been implicated in 
nuclear C to U RNA editing in mammalian cells [94],[95].  
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Figure 1. Alternative pre-mRNA splicing by CELF1 protein modulates the temporal and spatial 
diversity of genes during development. CELF1 binds to GU-rich intronic sequences in precursor mRNA 
and regulates exon inclusion or exon skipping during stage-specific alternative splicing transitions. 
CELF1-mediated regulation of alternative splicing is critical for maintenance of normal 
muscle structure and function [43],[96],[97].  Much of what we know about the role of CELF1 
in alternative splicing comes from studies investigating the role of CELF1 in the 
pathogenesis of the neuromuscular disease myotonic dystrophy type 1 (DM1).  In this 
disease, aberrant gain of CELF1 function is combined with a corresponding loss of function 
of the splicing factor MBNL1, resulting in the mis-splicing of a number of crucial genes 
(reviewed in [11]).  Minigene reporter systems that contain alternative splice sites proved to 
be a useful tools for the identification of pre-mRNA targets for CELF1, including genes for 
cardiac troponin T (TNNT2) [98], insulin receptor (INSR) [99], and chloride channel1 
(CLCN1) [100],[101].  Interestingly, these genes were all shown to be mis-regulated in tissues 
from patients who suffered from DM1.  Minigene systems have been particularly useful in 
demonstrating that individual pre-mRNA splicing events are affected by loss or gain of 
activities of specific regulatory proteins. Studies performed in cultured cells with transiently 
transfected minigenes have identified a number of alternative gene regions regulated by 
CELF1 and other family members [43], [69], [98], [99], [100], [101], [102], [103], [104], [105], 
[106],[107],[108]. However, as in other chimeric systems, the results of minigene 
overexpression experiments may not necessarily reflect the full-length pre-mRNA splicing 
patterns observed in vivo, especially during certain stages of organism development [109]. 
CELF proteins have been found to regulate the switch from fetal to adult  splicing patterns 
of several skeletal muscle transcripts through the use of transgenic mouse models 
[101],[100],[110]. In mice, splicing microarray studies found that nearly half of transcripts 
that undergo fetal-to-adult alternative splicing transitions in heart respond to over-
expression of CELF1, suggesting that the level of CELF1 activity directly regulates the  
alternative splicing pattern of endogenous transcripts [111].  The development of dominant 
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negative (DN) and tissue specific transgenic mice was advantageous for studying CELF-
specific alternative splicing in vivo [96],[104],[109],[110]. For example, dominant negative 
CELF (DNΔCELF) expressed under the control of a cardiac muscle-specific promoter, 
promoted the development of dilatated cardiomyopathy and cardiac dysfunction over time 
[96]. In contrast, when DNΔCELF was expressed under the control of a skeletal muscle-
specific promoter, mice exhibit reduction in muscle intersticia and an increase in slow twitch 
fibers [110]. In near future, we will see more phenotypic studies using a nucleus-restricted 
form of the dominant negative CELF protein which would specifically block only the CELF1 
nuclear function, leaving the cytoplasmic function intact [112], [113], [114]. 
5. CELF proteins as regulators of deadenylation, translation, and mRNA 
decay 
5.1. Deadenylation  
CELF1 plays important roles in mRNA stability and translation in diverse species. In 
eukaryotic organisms, the length of a transcript’s polyA tail influences the translational state 
of a transcript, and deadenylation is regulated by GU-rich sequences and CELF1 proteins 
across evolution. Regulation of translation through deadenylation in Xenopus embryos is the 
best characterized model of posttranscriptional gene regulation by CELF proteins.  In this 
model, the shortening or lengthening of the polyA tail causes activation or repression of 
translation of a number of transcripts [115]. However, as we describe below, deadenylation 
can also be the first step leading to mRNA degradation in mammalian cells, and the 
deadenylation machinery seems to be conserved although the consequences of 
deadenylation (translation or degradation) is regulated differently in diverse species.  
In Xenopus, maternal transcripts are stored in the cytoplasm of oocytes in a translationally 
silent form (reviewed in [116]). After fertilization of Xenopus oocytes, the CELF1 homologue 
EDEN-BP binds to the EDEN element which activates transcript deadenylation and leads to 
the translation of EDEN-containing mRNA transcripts, including transcripts that encode 
important cell cycle regulators [31],[33],[50],[117],[118],[119].  Furthermore, human CELF1, 
which has 88% identity with EDEN-BP, was able to functionally substitute for EDEN-BP to 
mediate transcript deadenylation in Xenopus extracts [51], suggesting that the deadenylation 
function of GU-rich sequences and CELF proteins were conserved in diverse species.  
Removal of the polyA tail is the rate-limiting step in the degradation of the majority of 
mammalian mRNAs [120],[121].  In human cell lines, CELF1 has been shown to associate 
with the deadenylase enzyme polyA ribonuclease (PARN) and to stimulate polyA tail 
shortening in a cell-free assay using S100 extracts from human cells [52].  It is not known if 
CELF1 activates other deadenylases in mammalian cells or how deadenylated transcripts 
are subsequently degraded.  PARN, EDEN-BP and cytoplasmic polyadenylation element-
binding proteins (CPEB) are present in Xenopus oocyte extracts [122], [123]. Theoretically, 
the balance between the rate of deadenylation versus polyadenylation depends upon the 
ability of EDEN-BP to recruit PARN and bind to polyA tail with higher affinity than CPEB 
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[122]. Since EDEN-BP in Xenopus is a regulator of deadenylation, it is likely that CELF1 also 
regulates deadenylation in mammalian cells, leading to transcript degradation through 
unknown mechanisms.   
5.2. Translation 
Translation is a critical layer of post-transcriptional control of gene expression that is 
regulated in response to environmental and developmental changes. CELF proteins have 
been shown to be involved in the activation of translation of several mRNA species at 
various stages of development [124]. Additionally, CELF proteins have been shown to 
function as inhibitors of translation under conditions of stress, where they act as 
translational silencers in conjunction with other protein binding partners. The involvement 
of CELF1 in translational regulation is evolutionarily conserved, with several CELF1 
homologues having been shown to regulate translation.  For example, in the Drosophila 
oocyte, translational repression is mediated by the protein Bruno (CELF1 orthologue), that 
binds specifically to bruno response elements (BREs) within the oskar mRNA 3'UTR. 
Binding by the CELF1 orthologue Bru-3 to GU-rich sequences in 3’UTR of gurken, cyclin A 
and oskar mRNA leads to their translational repression [44]. The suggested mechanism 
underlying Bru-3 mediated translational regulation is through the formation of a Bru-
3/eIF4E/5’-cap translational silencing complex during specific stages of embryo 
development [125].  CELF1 has also been shown to play a role in translational regulation in 
mammalian cells.  In human cell lines, tethering of CELF1 to the 3’UTR of mRNA through 
an interaction with the MS2 coat protein led to decreased steady state levels of reporter 
transcripts that contained a MS2 RNA-binding site, while reporter protein levels increased 
[126]. CELF1 increases the translation of p21 (CDKN1A28) protein [127], and Mef2a29 [128] 
during normal muscle cell differentiation via direct interaction with (GC)n repeats located 
within the 5’UTR of those mRNAs.  The data suggests that CELF1 mediates translational 
regulation through interaction with a G- and C-rich motif in the 5’UTR, whereas CELF1 
mediates its splicing and degradation effects through interaction with a G- and U-rich motif 
in introns and 3’UTRs, respectively.  Our experiments determining CELF1 binding targets 
through high-throughput means have failed to identify enrichment of GC-rich motifs or 
5’UTR binding by CELF1 [82].  It may be that CELF1 mediated translational regulation is 
rare, and only occurs in the context of very specific mRNA species and cellular contexts.  
Recently, an additional mechanism for CELF1 mediated translational regulation through 
interaction with the 3’UTR was discovered.  Binding of CELF1 to the 3’UTR of Serine 
hydroxymethyltransferase (SHMT) RNA [129],[130] and cyclin dependent kinase inhibitor 
p27 (Kip1) RNA [131], was found to regulate internal ribosome entry site (IRES) mediated 
translation activation.  This implicated CELF1 in participating in an IRES mode of initiation 
of mRNA translation. In addition, IRES translation is achieved through CELF1/hnRNPH 
complex formation, which promotes circularization of RNA transcripts by mediating 5’/3’ 
ends interactions [129]. Whether CELF1 recruits the translation machinery to the 5’UTR via 
additional interaction with eIF2 (Eukaryotic Initiation Factor 2) or another initiation factor 
remains to be determined (Figure 2).  
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Figure 2. Simplified representation of the role of CELF1 in mRNA translation.  Several mechanisms 
have been proposed for CELF1 mediated regulation of translation.  Many of these mechanisms involve 
CELF1 interacting with mRNA through sequences in the 5’UTR and subsequent translation via an 
internal ribosomal entry site. If (hyper)/phosphorylated, CELF1 interacts with eIF2 and other translation 
initiation factors, this serves to promote the production of truncated protein products. 
One well studied instance of CELF1 mediated translational control involves the translation 
of alternative isoforms of the transcription factor CCAAT/enhancer-binding protein 
(CEBPbeta) [132],[133],[134].  In a rat model, CELF1 phosphorylation was activated by 
partial hepatectomy, which promoted the formation of a complex between CELF1 and 
eIF2a. This subsequently led to selective translation of the liver enriched inhibitory protein 
(LIP) isoform of CCAAT/enhancer-binding protein [76]. It was later shown that in liver, 
CELF1 undergoes hyper-phosphorylation through a GSK3beta-cyclin D3-cdk4 kinase 
pathway, and the activity of this pathway seemed to increase with age [135]. Similar to the 
partial hepatectomy model, the cdk4-mediated hyper-phosphorylation of CELF1 was 
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involved in the age-associated induction of the CELF1-eIF2 complex [136].  In the rat aging 
model, the CELF1-eIF2 complex binds to the 5’UTR of HDAC1 mRNA and increases histone 
deacetylase 1 protein levels in aging liver [136],[137]. It was further shown that during rat 
aging, CELF1 phosphorylation promotes its interaction with a GC-rich sequence in 5’UTR of 
p21 mRNA causing p21 translational arrest and senescence in fibroblasts [138]. In myocytes, 
p21 mRNA is stabilized in discrete cytoplasmic structures called stress granules, which 
serve as reversible storage sites for mRNA under conditions of stress.  Interestingly, only 
during late senescence did p21s localization in stress granules interfere with its translation 
[138],[139].   One important component of stress granules is the RNA-binding protein T cell 
internal antigen 1 (TIA1).  Consistent with CELF1’s recruitment to stress granules, CELF1 
has been shown to function as a translational silencer through interaction with the TIA1 
protein [140]. Further support for this model comes from experiments utilizing DM1 cell 
harboring CUG repeat RNA.  The presence of a CUG repeat expansion was found to cause 
stress and activation of the PKR-phospho-eIF2α–CELF1 pathway leading to stress granule 
formation and inhibition of mRNA translation [81]. This disruption to physiologic mRNA 
translation pathways by cellular stress signals might contribute to the progressive muscle 
loss in DM1 patients. Taken together, this data suggests that CELF proteins may function as 
activators or repressors of translation, depending on the context. 
5.3. mRNA Decay 
Bioinformatic analysis of short lived-transcripts in primary human T cells led to the 
identification of the conserved, GU-rich element (GRE) enriched in transcript’s 3’UTRs.  
CELF1 was subsequently identified as a protein that specifically bound to the GRE in vitro 
and then to regulate the decay of exogenously expressed GRE-containing transcripts within 
cells [30],[141]. Further verification of the role of CELF1 in GRE-mediated mRNA decay 
came from the observation that in HeLa cells, siRNA-mediated knockdown of CELF1 led to 
stabilization of GRE-containing beta-globin reporter transcripts, as well as endogenous 
GRE-containing transcripts [30],[83],[142]. These results implicated CELF1 as a mediator of 
GRE-dependent mRNA decay. In primary human T cells, GREs and CELF1 appear to be 
involved in the rapid changes in gene expression patterns observed following T cell 
receptor-mediated activation.  Identification the cytoplasmic binding targets of CELF1 
before and after T cell activation led to the discovery that CELF1 dissociated from GRE-
containing transcripts following T cell activation in a manner correlated with a transient 
upregulation of CELF1 target mRNAs [77]. The dissociation of CELF1 from its target 
transcripts upon T cell activation was the result of an activation-dependent phosphorylation 
of CELF1 and a resultant decrease in the ability of CELF1 to bind to GRE-containing RNAs 
[77]. Many of the transiently up-regulated CELF1 target transcripts encoded proteins 
necessary for the transition from a quiescent state to a state of cellular activation and 
proliferation.  This supported a model whereby CELF1 suppresses a network of transcripts 
involved in activation and proliferation in resting T cells, and subsequent activation-
induced phosphorylation of CELF1 allows for de-repression and accumulation of these 
transcripts within activated cells.  
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In mouse myoblasts, cytoplasmic CELF1 bound hundreds of target transcripts that 
contained GU-rich sequences, including networks of transcripts that regulated cell cycle, 
intracellular transport and cell survival [55]. Knockdown of CELF1 in this myoblast cell line 
led to the stabilization of many endogenous GRE-containing targets, as well as luciferase 
reporter RNAs [88].  Many CELF1 target transcripts were found to be significantly stabilized 
in CELF1 knockout myoblasts, suggesting that CELF1 mediates the decay of a network of 
transcripts during myoblast growth and differentiation [55].  In the DM1 disease model, 
there is aberrant activation of the protein kinase C pathway as a result of the CTG 
expansion, and this results in CELF1 phosphorylation.  Mouse myoblasts (C2C12 cells) 
made to express CTG expanded RNA were shown to experience stabilization of tumor 
necrosis factor alpha (TNF-alpha) mRNA [143]. This result suggested that the over-
expression of TNF-alpha observed in DM1 could be coming from muscle, and this TNF-
alpha overexpression may contribute to the muscle wasting and insulin resistance that are 
characteristic of this disease [143]. In summary, CELF1 and its GRE-containing target 
transcripts define posttranscriptional regulatory networks that function to control cellular 
growth, activation, and differentiation (Figure 3).  
 
Figure 3. Evolutionary conservation of deadenylation by CELF1 protein and GU-rich sequences. (a). In 
Xenopus and Drosophila eggs, after fertilization, EDEN-BP (CELF1 homologue) bound to EDEN-
containing maternal mRNAs, causing deadenylation and subsequent translational activation. (b). In 
mammalian cells, CELF1 binds to GREs within the 3' UTR of specific transcripts and promotes their 
deadenylation (by deadenylases) and subsequent decay by the exosome. 
6. The GRE/CELF1 posttranscriptional network in human diseases 
The CELF family is an evolutionarily conserved family of RNA-binding proteins that plays 
an essential role in several aspects of post-transcriptional gene regulation and participates in 
(a) (b)
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the control of important developmental processes. Disruption of CELF1/GRE-mediated 
mRNA regulation may play a role in the pathophysiology of developmental defects 
[87],[113],[144], or cancer [145],[146]. In Xenopus, injecting “masking” oligonucleotides into 
embryos to specifically inhibit the binding of CELF1 to mRNA causes developmental 
defects, such as the loss of somatic segmentation [147]. Genetic deletion of CELF1 in 
Caenorhabditis elegans and transgenic mice caused severe developmental abnormalities and 
death [38],[45]. CELF1 knockout mice were mostly non-viable, but the few surviving pups 
displayed severe muscular and fertility defects [38]. The finding that CELF1 knockout mice 
displayed muscle pathophysiology was not surprising since CELF1 was first described as a 
protein that bound to the abnormally expanded CUG mRNA repeats occurring in patients 
with the neuromuscular disease: type I myotonic dystrophy [58],[59]. It has since been 
shown that the molecular pathogenesis of DM1 involves an increase in both nuclear and 
cytoplasmic CELF1 levels [148],[149] due to hyper-phosphorylation of the protein [74]. 
Kuyumcu-Martinez and colleagues reported that CELF1 hyper-phosphorylation was 
triggered by the presence of abnormal CUG repeats in DMPK RNA, which caused cellular 
stress and a resultant activation of the Protein kinase C stress response pathway.  This stress 
response and CELF1 hyper-phosphorylation was shown to trigger stabilization of the CELF1 
protein and thus upregulation in DM1 myoblasts [75]. The importance of CELF1 
upregulation is highlighted by the finding that over-expression of CELF1 in mouse heart 
and skeletal muscle recapitulated many of the aberrant splicing patterns observed in DM1 
patient tissues [54],[78],[97],[128],[148],[150]. Interestingly, the repression of CELF1 activity 
can restore normal alternative splicing events in transgenic mouse model of DM1 [114]. It 
has become increasingly clear that abnormal splicing underlies the molecular pathogenesis 
of muscular degenerative disorders, and in addition to occurring in muscle tissue, these 
splicing changes have been reported in brain tissues [151] which correlated with the 
presence of neurologic impairment [152] and abnormal Ca(2+) metabolism in DM1 patients 
[153]. DM1-like alternative splicing dysregulation and altered expression of CELF1 also 
occurs in mouse models of other muscular dystrophies and muscle injury, most likely due to 
recapitulation of neonatal splicing patterns in regenerating fibers [113]. CELF1 function is 
altered in other neuromuscular diseases due to its sequestration to nuclear inclusions in 
oculopharyngeal muscular dystrophy (OPMD) [154], fragile-X-associated tremor/ataxia 
syndrome [152], and in spinal bulbar muscular atrophy [155], suggesting a key role for this 
protein in muscle pathophysiology.  It will be interesting to investigate whether altered 
CELF1 regulation in muscle diseases could also have deleterious effects through altering the 
stability of GU-rich mRNA targets, given the role of CELF1 in mRNA decay. The discovery 
of disease-causing splicing patterns in muscle disease has yielded a wealth of information 
about both physiologic and dysregulated RNA biology and this information is currently 
being leveraged to develop novel therapies for DM1 and other RNA based neuromuscular 
disorders [156]. 
Despite the fact that the field of CELF1 biology is relatively young, there is some data 
supporting a potential link between dysregulated CELF1 mediated RNA metabolism and a 
cancerous phenotype.  One recent study found CELF1 to be one to the top ten candidates in 
a transposon-based genetic screen in mice to identify potential drivers of colorectal 
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tumorigenesis [157]. Additionally, CELF1 expression has been shown to be lost through a 
t(1;11)(q21;q23) translocation in certain forms of pediatric acute leukemia [158].  One way in 
which disruption of CELF1 may contribute to a malignant phenotype is through 
disregulation of C/EBPbeta expression.  In HER2-overexpressing breast cancer cells CELF1 
is activated favoring the production of the C/EBPbeta transcription-inhibitory isoform LIP 
over that of the active isoform LAP, and this contributed to evasion of TGFbeta and 
oncogene-induced senescence [146]. Treatment of HER2-transformed metastatic breast 
cancer cells with the anti-HER2/neu monoclonal antibody trastuzumab reduced CELF1 
protein level and it’s activity, suggesting that the targeting of CELF1 may be a viable adjunct 
therapy in the treatment of breast cancer [159].  Expressions of C/EBPbeta and C/EBPalfa are 
translationally repressed in BCR/ABL cells (chronic myelogenous leukemia) and it can be re-
induced by imatinib via a mechanism that appears to depend on the activity of CELF1 and 
the integrity of the CUG-rich intercistronic region of C/EBPbeta mRNA [160],[161].   
Another potential mechanism of CELF1 mediated tumor promotion comes from our lab’s 
results of RIP-Chip experiments investigating CELF1’s targets in normal and malignant 
cells. In primary human T cells, we observed that CELF1 bound to a large number of 
transcripts involved in cell cycle and apoptosis regulation pathways, and that upon 
activation and proliferation of these cells, CELF1 bound to a drastically reduced mRNA 
population [77].  This result suggests that CELF1 inhibition is correlated with a cellular state 
of proliferation and altered apoptotic response. We also identified hundreds of CELF1 target 
transcripts in human HeLa cells (carcinoma cell line) and many of these transcripts were 
different than those in normal T cells suggesting again that altered CELF1’s RNA binding 
specificity may correlate with malignancy [82].     
CELF1-HDAC1-C/EBPbeta pathway is activated in young rat liver cells and in human 
tumor liver samples suggesting that CELF1-HDAC1-C/EBPbeta complexes are involved in 
the development of liver tumors [162],[163]. The inhibition of the ubiquitin-dependent 
proteasome system (UPS) via specific drugs (such as Bortezomib) is one type of approach 
used to combat cancer [164]. Gareau et. al. showed that CELF1 is required for p21 mRNA 
stabilization and localization in stress granules induced upon treatment with Bortezomib.  
The authors postulated that this may allow cancer cells survive stress and escape apoptosis 
[165]. This mechanism may explain why some tumors are refractory to Bortezomib 
treatment.   
Thus, the dysregulation of CELF1 and GREs appears to contribute to malignant phenotype, 
perhaps by abrogating its ability to mediate the rapid and timely degradation of GRE-
containing growth-regulatory transcripts and promote translation of some cell cycle 
regulators and oncogenes.  
7. Conclusion 
In summary, we have learned a wealth of information about CELF1-mRNA complexes and 
their importance in development, regeneration, aging and disease. CELF1 binds 
preferentially to GRE-containing transcripts, and affects expression of transcripts encoding 
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other transcription factors and RNA-binding proteins that regulate cell growth, apoptosis, 
and development/differentiation (reviewed in [28],[166]). Thus, CELF1 may be functioning 
as a posttranscriptional “regulator of regulators”, whereby CELF1 influences the expression 
of a network of target transcripts encoding RNA/DNA binding proteins. This, in turn 
regulates individual subnetworks of transcripts necessary for development or 
environmental responses, such as immune activation, requiring transition from a quiescent 
state to a state of cellular activation and proliferation.  
Understanding gene regulatory networks and the integration of transcriptional and 
posttranscriptional events are the next important tasks in translational medicine. It will 
require innovations in computational methods, experimental techniques and new animal 
models. It is also important to further investigate in vivo biochemical interactions between 
CELF proteins and RNA, to discover unknown components of CELF protein-containing 
complexes bound to RNA that may be involved in splicing, deadenylation, decay, and/or 
translation regulation.  The lists of conserved RNA-binding proteins and mRNA cis-elements 
has been expanding over the past decade, but the mechanisms of the precise assembly of 
RNA-binding complexes in an orchestrated temporal and spatial manner have not been 
comprehensively described.  Furthermore, little work has been done on how the  expression 
and function of CELF1 is regulated, specifically by  microRNAs (such as mir-222 [167], mir-
503 [168], and miR-23a/b [169]). The more details we learn about intracellular signaling, cross-
talk, molecular assembly and localization of RNA-protein complexes, the more unifying 
principles we may find. Understanding the biochemistry of posttranscriptional regulation 
will lead to elucidation of posttranscriptional regulatory pathways and networks and lead to 
a better understanding of normal cellular function and disease states. 
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